? Mike Stadnisky - Thielsen Capital - Part 3 | Don’t Fake it ‘Til you Make It | Cleaning Your Corporate “Underwear” | Thielsen’s Investment Philosophy | The Critical Importance of Alignment

Maneesh Jain - Mirvie - Part 3 | Finding & Addressing Unmet Needs | The Maternal Health Crisis | Creating an Empathy-Focused Company Culture | Fundraising & Hitting Milestones in a Recession: Part 3 of 3. My guest for this week’s episode is Maneesh Jain, CEO and Co-Founder of Mirvie, a life science company that predicts pregnancy complications before they happen by revealing the underlying biology of pregnancy health. Mirvie is dedicated to shaping the future of pregnancy health through simple, personalized blood tests. Before Mirvie, Maneesh was a founder, CEO, or executive of five successful start-ups, which include Parallele Bioscience, Auriphex Bioscience, Ion Torrent, Butterfly Network, and Cirina. by The Biotech Startups Podcast

26 min listen

The Biotech Startups Podcast Trailer: Coming soon... The Biotech Startups Podcast by Excedr. We will be speaking with first-time founders, experienced scientists, long-time company operators, serial entrepreneurs, and biotech investors about the challenges and triumphs of running a biotech startup. by The Biotech Startups Podcast

1 min listen

Jacob Glanville - Centivax - Part 1 | Hospitality Industry’s Applied Lessons | The Benefits of Contingency Planning & Fair Negotiation | How to Seek Translational Skill Sets & Cross Training: In the first ever episode of The Biotech Startups Podcast, Host Jon Chee is joined by Jake Glanville of Centivax! They discuss his upbringing in Guatemala; the parallels between the hospitality service and medicine; how to become more approachable to customers; and the power of saying ‘no’ to people in the industry. by The Biotech Startups Podcast

25 min listen

James Evans - PhenoVista - Part 2 | Leaving Academia for Industry | How to Handle Miscommunication | Creating a Truly Diverse Company Culture | Being Bootstrapped & Forging a Business Model in the Real World: Part 2 of 3. My guest for this week’s episode is James Evans, Founder and CEO of PhenoVista Biosciences, a contract research organization that works with biopharma clients of all sizes, from start-ups to established global companies. by The Biotech Startups Podcast

22 min listen

Jacob Glanville - Centivax - Part 2 | Creating Bioinformatic Tools | Innovation vs. Organization in Biotech Companies | Finding Excitement in Your Work | Tech Transfer & “Separation of Church and State”: In part 2 of the Biotech Startups Podcast episode, host Jon Chee dives deeper into his conversation with Jacob Glanville, Founder, CEO, & President of Centivax. Jake sheds light on his past experiences at Rinat Labs, a Pfizer company, and how he found a way to leverage his skills and experience to create new bioinformatic processes. Learn more about his initial idea for a universal vaccine and why he chose to pursue a PhD at Stanford. by The Biotech Startups Podcast

31 min listen

Jacob Glanville - Centivax - Part 3 | Building a Biotech without Venture Capital | Picking Lab Space & Company Growth | Equipment Leasing & Runway/Cash Flow Maximization | Process Drift & “The Respiration Model”: Jacob is the Founder, CEO, & President of Centivax and was formerly the Co-founder, CEO, and President of Distributed Bio. Join us as we sit down with Jake, discussing his three-part plan for building Distributed Bio without traditional venture capital, how reality differed from the plan, and how the acquisition by Charles River Laboratories occurred. Learn more about his thoughts on natural team growth and how to handle process drift. Hear Jake’s view on how equipment leasing provided a solution for growing a business when cash was tight and needed for investing in internal operations. Discover Jake’s insight into what he calls “the respiration model” of leadership, balancing hierarchical and organic structures to promote organization and innovation. Hear more about his exper by The Biotech Startups Podcast

35 min listen

Steve Visco - PolyPlus - Part 1 | Benefits of Strong Writing Skills for Entrepreneurs | Tech Transfer Process & Its Origins | Leveraging Your Expert Status in Negotiations to Gain Investment | Evaluating Personal Needs Alongside Professional Opportunities: Part 1 of 3. My guest for this week’s episode is Steve Visco. Steve is the Co-founder, CTO, and CEO of PolyPlus. Before PolyPlus, Steve worked at Lawrence Berkeley National Lab as a Principal Investigator, running several programs in the field of solid state ionics, developing an extensive patent portfolio, much of which has been licensed to industry. by The Biotech Startups Podcast

36 min listen

Alok Tayi - Vibe Bio - Part 1 | Combining Software & Science | The Influence of Serendipity of Trajectory | The Critical Importance of Mentors | Working to Make an Impact & Solve Problems: Part 1 of 3. My guest for this week’s episode is Alok Tayi, Founder of Vibe Bio, a life science company focused on funding & guiding high-potential drug programs through value inflection points. Vibe Bio’s core is a community of scientists, patients, and partners that are dedicated to helping biotechs find the promising treatments that patients deserve. by The Biotech Startups Podcast

30 min listen

? Sandy Paige - Seabright Ventures Fund - Part 1 | The Value of Hustle & Being a Team Player | Saying Yes to Opportunities | Corporate Entrepreneurship & Finding Your Path | Entrepreneurs & Risk Aversion: Part 1 of 4. My guest for this week’s episode is Sandy Paige, co-managing director of the Seabright Ventures Fund, a search fund investing in the US middle market, with a focus on life sciences and cleantech. Sandy is an expert CEO, most recently leading and scaling Explora BioLabs before its acquisition by Charles River Laboratories for $295 Million dollars. by The Biotech Startups Podcast

31 min listen

Alok Tayi - Vibe Bio - Part 3 | Biotech2050 Podcast Origins | Facilitating Innovation Conversations in Biotech | Vibe Bio’s Mission & Funding Cures Instead of Finding Them | Non-Linear Growth & Thinking Long Term: Part 3 of 3. My guest for this week’s episode is Alok Tayi, Founder of Vibe Bio, a life science company that funds and guides high-potential drug programs through value inflection points. Vibe Bio’s core comprises a community of scientists, patients, and partners dedicated to helping biotechs find the promising treatments that patients deserve. by The Biotech Startups Podcast

27 min listen

Jacob Glanville - Centivax - Part 4 | How to Choose the Right Venture Capital Partner | Fundraising as “Dating” | Finding Proper Alignment & The Win-Win | VC Network as a “Polishing Engine”: My guest for this week’s episode is Jacob Glanville. Jacob is the Founder, CEO, and President of Centivax and was formerly the Co-founder, CEO, and President of Distributed Bio. Join us as we sit down with Jake to discuss: how important it is to understand a venture capital firm’s investment thesis and values, tips to successfully pitch to them, the perks of viewing potential VC relationships as “dating,” and how that mindset can help you find the right partner. by The Biotech Startups Podcast

31 min listen

Steve Visco - PolyPlus - Part 2 | Global Competition | Defending & Monetizing Your Intellectual Property | Dealing With Patent Trolls & Needing Multiple Patents Per Technology | The Importance of Global IP Strategy for Startups: Part 2 of 3. My guest for this week’s episode is Steve Visco. Steve is the Co-founder, CTO, and CEO of PolyPlus. Before PolyPlus, Steve worked at Lawrence Berkeley National Lab as a Principal Investigator, running several programs in the field of solid state ionics, developing an extensive patent portfolio, much of which has been licensed to industry. by The Biotech Startups Podcast

34 min listen

James Evans - Phenovista - Part 1 | Skateboarding, Resilience, & Problem Solving | The Importance of Hands-On Lab Experiences | The Elegant Simplicity of Trial & Error | Running the Whitehead Institute’s Core Facility: Part 1 of 3. My guest for this week’s episode is James Evans, Founder and CEO of PhenoVista Biosciences, a contract research organization that works with biopharma clients of all sizes, from start-ups to established global companies. by The Biotech Startups Podcast

28 min listen

Alok Tayi - Vibe Bio - Part 2 | Transitioning Into Entrepreneurship | The Importance of Sales Experience for Founders | The Power of a .edu Email | Managing Personnel During Hyperscaling: Part 2 of 3. My guest for this week’s episode is Alok Tayi, Founder of Vibe Bio, a life science company focused on funding & guiding high-potential drug programs through value inflection points. Vibe Bio’s core comprises a community of scientists, patients, and partners dedicated to helping biotechs find the promising treatments that patients deserve. by The Biotech Startups Podcast

27 min listen

Maneesh Jain - Mirvie - Part 2 | Company Size & Innovation | Supply Chain Learnings from Other Industries | Scaling Go-to-Market Strategies | Culture’s Interaction with Mergers & Acquisitions: Part 2 of 3. My guest for this week’s episode is Maneesh Jain, CEO and Co-Founder of Mirvie, a life science company that predicts pregnancy complications before they happen by revealing the underlying biology of pregnancy health. Mirvie is dedicated to shaping the future of pregnancy health through simple, personalized blood tests. by The Biotech Startups Podcast

29 min listen

Steve Visco - PolyPlus - Part 3 | Government Grants | The Importance of Storytelling for STEM Startups | Venture Capital vs Non-Dilutive Funding | How To Gain Strategic Corporate Interest Domestically & Abroad: Part 3 of 3. My guest for this week’s episode is Steve Visco. Steve is the Co-founder, CTO, and CEO of PolyPlus. Before PolyPlus, Steve worked at Lawrence Berkeley National Lab as a Principal Investigator, running several programs in the field of solid state ionics, developing an extensive patent portfolio, much of which has been licensed to industry. by The Biotech Startups Podcast

37 min listen

James Evans - PhenoVista - Part 3 | Being a Scrappy Founder | Adapting to Change & Learning to Pivot | The Importance of Professional Business Development | Setting Client Expectations: Part 3 of 3. My guest for this week’s episode is James Evans, Founder and CEO of PhenoVista Biosciences, a contract research organization that works with biopharma clients of all sizes, from start-ups to established global companies. by The Biotech Startups Podcast

19 min listen

Maneesh Jain - Mirvie - Part 1 | Fundamental Curiosity & The Value of Perseverance | Entrepreneurship for Societal Impact | “Magic Decades” & Finding Your Niche | The Importance of Scalability & Differentiation: Part 1 of 3. My guest for this week’s episode is Maneesh Jain, CEO and Co-Founder of Mirvie, a life science company that predicts pregnancy complications before they happen by revealing the underlying biology of pregnancy health. Mirvie is dedicated to shaping the future of pregnancy health through simple, personalized blood tests. Before Mirvie, Maneesh was a founder, CEO, or executive of five successful start-ups, which include Parallele Bioscience, Auriphex Bioscience, Ion Torrent, Butterfly Network, and Cirina. by The Biotech Startups Podcast

31 min listen

? Fengru Lin - TurtleTree - Part 1 | Growing Up in Hong Kong & Singapore | Serendipity & Its Effect on Career Paths | Connecting the Dots in Business | The Complex & Fragile World of Food Production | The Importance of QA/QC: Part 1 of 3. My guest for this week’s episode is Fengru Lin, Founder and CEO of TurtleTree, a biotech company revolutionizing food for good. Having raised a 40 million dollar Series A, TurtleTree is creating cell-based milk, with a current focus on releasing LF+, the world’s first sustainably produced lactoferrin made with cutting-edge precision fermentation technology. Prior to TurtleTree, Fengru worked at UL, Salesforce, and Google, gaining a tremendous amount of experience in sales and business development. by The Biotech Startups Podcast

23 min listen

? Fengru Lin - TurtleTree - Part 2 | Salesforce’s Customer-Centric Sales Motion | The Value of Knowing Your Audience in Every Conversation | Why Executive Buy-In Matters | How a Hobby Led to TurtleTree’s Founding Idea: Part 2 of 3. My guest for this week’s episode is Fengru Lin, Founder and CEO of TurtleTree, a biotech company revolutionizing food for good. Having raised a 40 million dollar Series A, TurtleTree is creating cell-based milk, with a current focus on releasing LF+, the world’s first sustainably produced lactoferrin made with cutting-edge precision fermentation technology. by The Biotech Startups Podcast

24 min listen

? Kittu Kolluri - Neotribe Ventures - Part 1 | Entrepreneurship as a First-Generation Immigrant | Working & Growing at Silicon Graphics | Learning From Mistakes & Pride of Ownership | The Dangers of Company Microcultures: Part 1 of 3. My guest for this week’s episode is Kittu Kolluri, Founder and Managing Director of Neotribe Ventures, an early- and growth-stage venture capital firm investing in companies that solve hard technical problems and disrupt non-traditional industry sectors. Neotribe is led by a team of serial entrepreneurs with a track record of supporting and advising startups from seed round to IPO. by The Biotech Startups Podcast

35 min listen

? Sandy Paige - Seabright Ventures Fund - Part 4 | Creating Competitive Moats | Leveraging Financing Opportunities for Growth | The Purpose of a Board of Directors | Ambiguity as an Asset & Avoiding the Bias Toward Action: Part 4 of 4. My guest for this week’s episode is Sandy Paige, co-managing director of the Seabright Ventures Fund, a search fund investing in the US middle market, with a focus on life sciences and cleantech. by The Biotech Startups Podcast

29 min listen

? Sandy Paige - Seabright Ventures Fund - Part 3 | Managing International Distribution | Meaningful Work & Personal Buy-In as a Form of Equity | Getting Into Business Development & The Importance of Sales Experience | Starting & Running a Search Fund: Part 3 of 4. My guest for this week’s episode is Sandy Paige, co-managing director of the Seabright Ventures Fund, a search fund investing in the US middle market, with a focus on life sciences and cleantech. Sandy is an expert CEO, most recently leading and scaling Explora BioLabs before its acquisition by Charles River Laboratories for $295 Million. by The Biotech Startups Podcast

24 min listen

? Kittu Kolluri - Neotribe Ventures - Part 2 | The Importance of Co-Authoring a Culture Statement | The Difference Between Leadership & Management | Raising Funds in Down-Market Conditions | The Value of Authenticity & Intellectual Curiosity: Part 2 of 3. My guest for this week’s episode is Kittu Kolluri, Founder and Managing Director of Neotribe Ventures, an early- and growth-stage venture capital firm investing in companies that solve hard technical problems and disrupt non-traditional industry sectors. by The Biotech Startups Podcast

32 min listen

? Fengru Lin - TurtleTree - Part 3 | The Value of Early HR for Company Building | Creating a People-First Work Culture | Refocusing to Reach Commercialization Sooner | Navigating Seed Series Fundraising: Part 3 of 3. My guest for this week’s episode is Fengru Lin, Founder and CEO of TurtleTree, a biotech company revolutionizing food for good. Having raised a 40 million dollar Series A, TurtleTree is creating cell-based milk, with a current focus on releasing LF+, the world’s first sustainably produced lactoferrin made with cutting-edge precision fermentation technology. by The Biotech Startups Podcast

29 min listen

? Sandy Paige - Seabright Ventures Fund - Part 2 | Practicing Corporate Entrepreneurship | Life Lessons on How to Treat People | Seeking Margins & Avoiding Commodity | Scaling a Non-Profit | A CEO’s 3-5 Important Yearly Decisions: Part 2 of 4. My guest for this week’s episode is Sandy Paige, co-managing director of the Seabright Ventures Fund, a search fund investing in the US middle market, with a focus on life sciences and cleantech. Sandy is an expert CEO, most recently leading and scaling Explora BioLabs before its acquisition by Charles River Laboratories for $295 Million. by The Biotech Startups Podcast

36 min listen

? Kittu Kolluri - Neotribe Ventures - Part 3 | Influence vs Control as a VC | Being a Leader in Venture vs a Leader in a Company | Starting Neotribe as a Passionate Rage Against the Status Quo | Sunk Cost vs Opportunity Cost | Optimizing Customer Acquisit: Part 3 of 3. My guest for this week’s episode is Kittu Kolluri, Founder and Managing Director of Neotribe Ventures, an early- and growth-stage venture capital firm investing in companies that solve hard technical problems and disrupt non-traditional industry sectors. by The Biotech Startups Podcast

37 min listen

? Stephanie Sirota - RTW Investments - Part 2 | Understanding Investment Banking’s Role in the Biosciences | Finding the Benefits of Your Uniqueness | Unexpected Pivots & Finding Passion in Your Work | Advice on Dealing with Bear Markets: Part 2 of 3. My guest for this week’s episode is Stephanie Sirota, Partner, and Chief Business Officer at RTW Investments, a full lifecycle life sciences investment firm dedicated to solving the most challenging unmet patient needs. Stephanie is a seasoned expert and leader in business development, strategic partnerships, communications, and investor relations. by The Biotech Startups Podcast

33 min listen

? Stephenie Sirota - RTW Investments - Part 3 | The Emergence of Crossover Rounds | Building & Explaining Your Investment Thesis | Creating a .600 Batting Average Investment Fund | Transparency Between Investor & Founder | How to Get LPs to Say “Yes”: Part 3 of 3. My guest for this week’s episode is Stephanie Sirota, Partner, and Chief Business Officer at RTW Investments, a full lifecycle life sciences investment firm dedicated to solving the most challenging unmet patient needs. Stephanie is a seasoned expert and leader in business development, strategic partnerships, communications, and investor relations. by The Biotech Startups Podcast

31 min listen

? Martin Brenner - iBio - Part 2 | Autonomy at Eli Lilly vs. Structure at Pfizer | Transitioning from AstraZeneca to Merck | Joys & Challenges When Relocating for Work | A Biotech Vision Leading to an Exit From Big Pharma: Part 2 of 3. My guest for this week’s episode is Martin Brenner, CEO and CSO of iBio. iBio uses its AI drug discovery platform to tackle complex and challenging drug targets to develop safer and more effective immunotherapies for difficult-to-treat cancers. Rather than leaving drug discovery to chance, iBio guides the process using artificial intelligence, making therapeutic development smarter, faster, and more precise. by The Biotech Startups Podcast

37 min listen

Discover this podcast and so much more

? Mike Stadnisky - Thielsen Capital - Part 3 | Don’t Fake it ‘Til you Make It | Cleaning Your Corporate “Underwear” | Thielsen’s Investment Philosophy…

? Mike Stadnisky - Thielsen Capital - Part 3 | Don’t Fake it ‘Til you Make It | Cleaning Your Corporate “Underwear” | Thielsen’s Investment Philosophy…

Description

Titles in the series (46)

More Episodes from The Biotech Startups Podcast

Related podcast episodes